Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Biqi Zhou

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Leukemia & Lymphoma|June 18, 2026
Efficacy of allogeneic haematopoietic stem cell transplantation in acute myeloid leukemia with myelodysplasia-related geneticsJingwen Rui, Rui Gao, Yifan Shen, et al.
Transplantation Proceedings|September 14, 2025
The Application of Personalized Conditioning Regimens in Relapsed/Refractory Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Stem Cell TransplantationShuangzhu Liu, Biqi Zhou, Chongsheng Qian, et al.
Annals of Hematology|August 10, 2018
Clinical outcome of granulocyte transfusion therapy for the treatment of refractory infection in neutropenic patients with hematological diseasesBiqi Zhou, Tiemei Song, Yufeng Feng, et al.
American Journal of Hematology|August 18, 2021
The clinical outcomes and genomic landscapes of acute lymphoblastic leukemia patients with E2A-PBX1: A 10-year retrospective studyBiqi Zhou, Xinran Chu, Hong Tian, et al.
Transplantation and Cellular Therapy|February 1, 2023
Evaluation of the Diagnostic Performance of Plasma Metagenomic Next-Generation Sequencing in Febrile Events in the First 30 Days after Chimeric Antigen Receptor T Cell InfusionDanya Shen, Biqi Zhou, Meng Shan, et al.
Leukemia & Lymphoma|November 16, 2020
Allogeneic hematopoietic stem cell transplantation could improve survival for pure CBF-AML patients with minimal residual disease positive after the second consolidationTanzhen Wang, Biqi Zhou, Jubin Zhang, et al.
Transplantation and Cellular Therapy|December 26, 2021
Clinical Outcomes of B Cell Acute Lymphoblastic Leukemia Patients Treated with Haploidentical Stem Cells Combined with Umbilical Cord Blood TransplantationBiqi Zhou, Mimi Xu, Shenqi Lu, et al.
International Journal of Hematology|February 7, 2019
Prognostic values of increased B7 family proteins in haploidentical hematopoietic stem cell transplantation patients with aGVHDBiqi Zhou, Tanzhen Wang, Lei Lei, et al.
Translational Cancer Research|November 17, 2022
<i>LPCAT3</i> is a potential prognostic biomarker and may be correlated with immune infiltration and ferroptosis in acute myeloid leukemia: a pan-cancer analysisPeng Ke, Xiebing Bao, Chenxi Liu, et al.
Hematological Oncology|April 14, 2025
Clinical Outcomes of CD7 CAR-T Cell Therapy in Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma PatientsJinyan Xiao, Yujie Liu, Yifan Shen, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Leukemia & Lymphoma|June 18, 2026
Efficacy of allogeneic haematopoietic stem cell transplantation in acute myeloid leukemia with myelodysplasia-related geneticsJingwen Rui, Rui Gao, Yifan Shen, et al.
Transplantation Proceedings|September 14, 2025
The Application of Personalized Conditioning Regimens in Relapsed/Refractory Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Stem Cell TransplantationShuangzhu Liu, Biqi Zhou, Chongsheng Qian, et al.
Annals of Hematology|August 10, 2018
Clinical outcome of granulocyte transfusion therapy for the treatment of refractory infection in neutropenic patients with hematological diseasesBiqi Zhou, Tiemei Song, Yufeng Feng, et al.
American Journal of Hematology|August 18, 2021
The clinical outcomes and genomic landscapes of acute lymphoblastic leukemia patients with E2A-PBX1: A 10-year retrospective studyBiqi Zhou, Xinran Chu, Hong Tian, et al.
Transplantation and Cellular Therapy|February 1, 2023
Evaluation of the Diagnostic Performance of Plasma Metagenomic Next-Generation Sequencing in Febrile Events in the First 30 Days after Chimeric Antigen Receptor T Cell InfusionDanya Shen, Biqi Zhou, Meng Shan, et al.
Leukemia & Lymphoma|November 16, 2020
Allogeneic hematopoietic stem cell transplantation could improve survival for pure CBF-AML patients with minimal residual disease positive after the second consolidationTanzhen Wang, Biqi Zhou, Jubin Zhang, et al.
Transplantation and Cellular Therapy|December 26, 2021
Clinical Outcomes of B Cell Acute Lymphoblastic Leukemia Patients Treated with Haploidentical Stem Cells Combined with Umbilical Cord Blood TransplantationBiqi Zhou, Mimi Xu, Shenqi Lu, et al.
International Journal of Hematology|February 7, 2019
Prognostic values of increased B7 family proteins in haploidentical hematopoietic stem cell transplantation patients with aGVHDBiqi Zhou, Tanzhen Wang, Lei Lei, et al.
Translational Cancer Research|November 17, 2022
<i>LPCAT3</i> is a potential prognostic biomarker and may be correlated with immune infiltration and ferroptosis in acute myeloid leukemia: a pan-cancer analysisPeng Ke, Xiebing Bao, Chenxi Liu, et al.
Hematological Oncology|April 14, 2025
Clinical Outcomes of CD7 CAR-T Cell Therapy in Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma PatientsJinyan Xiao, Yujie Liu, Yifan Shen, et al.
Pageof 2